These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus. Liang XH; Sun H; Nichols JG; Crooke ST Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo biophysical properties of oligonucleotides containing 5'-thio nucleosides. Islam MA; Waki R; Fujisaka A; Ito KR; Obika S Drug Discov Ther; 2016; 10(5):263-270. PubMed ID: 27890900 [TBL] [Abstract][Full Text] [Related]
29. Structural requirements at the catalytic site of the heteroduplex substrate for human RNase H1 catalysis. Lima WF; Nichols JG; Wu H; Prakash TP; Migawa MT; Wyrzykiewicz TK; Bhat B; Crooke ST J Biol Chem; 2004 Aug; 279(35):36317-26. PubMed ID: 15205459 [TBL] [Abstract][Full Text] [Related]
30. 2'β-Fluoro-Tricyclo Nucleic Acids (2'F-tc-ANA): Thermal Duplex Stability, Structural Studies, and RNase H Activation. Istrate A; Katolik A; Istrate A; Leumann CJ Chemistry; 2017 Aug; 23(43):10310-10318. PubMed ID: 28477335 [TBL] [Abstract][Full Text] [Related]
31. How RNase HI (Escherichia coli) promoted site-selective hydrolysis works on RNA in duplex with carba-LNA and LNA substituted antisense strands in an antisense strategy context? Plashkevych O; Li Q; Chattopadhyaya J Mol Biosyst; 2017 May; 13(5):921-938. PubMed ID: 28352859 [TBL] [Abstract][Full Text] [Related]
32. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides. Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362 [TBL] [Abstract][Full Text] [Related]
33. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Gao WY; Han FS; Storm C; Egan W; Cheng YC Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582 [TBL] [Abstract][Full Text] [Related]
34. XRN2 is required for the degradation of target RNAs by RNase H1-dependent antisense oligonucleotides. Hori S; Yamamoto T; Obika S Biochem Biophys Res Commun; 2015 Aug; 464(2):506-11. PubMed ID: 26159921 [TBL] [Abstract][Full Text] [Related]
35. RNase H is responsible for the non-specific inhibition of in vitro translation by 2'-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers. Larrouy B; Boiziau C; Sproat B; Toulmé JJ Nucleic Acids Res; 1995 Sep; 23(17):3434-40. PubMed ID: 7567453 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of ( Zhou Y; Kajino R; Ishii S; Yamagishi K; Ueno Y RSC Adv; 2020 Nov; 10(68):41901-41914. PubMed ID: 35516588 [TBL] [Abstract][Full Text] [Related]
37. Alpha beta chimeric antisense oligonucleotides: synthesis and nuclease resistance in biological media. Gottikh M; Bertrand JR; Baud-Dematteï MV; Lescot E; Giorgi-Renault S; Shabarova Z; Malvy C Antisense Res Dev; 1994; 4(4):251-8. PubMed ID: 7734939 [TBL] [Abstract][Full Text] [Related]
38. Is irrelevant cleavage the price of antisense efficacy? Stein CA Pharmacol Ther; 2000 Mar; 85(3):231-6. PubMed ID: 10739877 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, biophysical properties, and RNase H activity of 6'-difluoro[4.3.0]bicyclo-DNA. Frei S; Katolik AK; Leumann CJ Beilstein J Org Chem; 2019; 15():79-88. PubMed ID: 30680042 [TBL] [Abstract][Full Text] [Related]
40. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo. Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]